Bempedoic acid in patients with type 2 diabetes mellitus, prediabetes, and normoglycaemia: A post hoc analysis of efficacy and glycaemic control using pooled data from phase 3 clinical trials.

Lawrence A LeiterMaciej BanachAlberico L CatapanoP Barton DuellAntonio M GottoUlrich LaufsG B John ManciniKausik K RayJeffrey C HanselmanZhan YeHarold E Bays

Published in: Diabetes, obesity & metabolism (2022)

Bempedoic acid significantly lowered LDL-C across glycaemic strata and did not worsen glycaemic variables or increase the incidence of new-onset diabetes versus placebo over a median follow-up of 1 year.

Keyphrases

type diabetes
clinical trial
glycemic control
phase iii
cardiovascular disease
risk factors
insulin resistance
electronic health record
big data
double blind
metabolic syndrome
machine learning
phase ii